Immunomedics (IMMU) Misses Q1 EPS by 3c

November 3, 2016 7:30 AM EDT
Get Alerts IMMU Hot Sheet
Trade IMMU Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $129.2 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment